EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel therapeutic targets for reperfusion injury in ischemic stroke: Understanding the role of mitochondria, excitotoxicity and ferroptosis

Vidhi Anupam Awasthi, Vaibhav Dhankar, Shamsher Singh

Vascular Pharmacology · 2024

DOI: 10.1016/j.vph.2024.107413 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2024. Verfasst von Vidhi Anupam Awasthi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Punjab, India. Hauptthemen laut MEDLINE: Ferroptosis, Reperfusion Injury, Mitochondria, Ischemic Stroke. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: JSS College of Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic reperfusion injury (IRI) remains a significant challenge in various clinical settings, including stroke. Despite advances in reperfusion strategies, the restoration of blood flow to ischemic tissues often exacerbates tissue damage through a complex cascade of cellular and molecular events. In recent years, there has been growing interest in identifying novel therapeutic targets to ameliorate the detrimental effects of IRI and improve patient outcomes. This review critically evaluates emerging therapeutic targets and strategies for IRI management, such as R-spondin 3, neurolysin, glial cell gene therapy and inter alpha inhibitors. Diverse pathophysiology involved in IRI stroke such as oxidative stress, inflammation, mitochondrial dysfunction, and ferroptosis are also closely discussed. Additionally, we explored the intricate interplay between inflammation and IRI, focusing on cell-mediated gene therapy approaches and anti-inflammatory agents that hold promise for attenuating tissue damage. Moreover, we delve into novel strategies aimed at preserving endothelial function, promoting tissue repair, and enhancing cellular resilience to ischemic insults. Finally, we discuss challenges, future directions, and translational opportunities for the development of effective therapies targeting ischemic reperfusion injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisReperfusion InjuryMitochondriaIschemic StrokeOxidative StressSignal TransductionHumansAnimalsAnti-Inflammatory AgentsBrainMolecular Targeted TherapyInflammation Mediators

Stichwörter der Autor:innen

Anti-inflammatoryNeuroinflammationNeurolysinNeuroprotectionNovel therapeutic targetsOxidative stressR-spondinStroke

Substanzen

Anti-Inflammatory AgentsInflammation Mediators

Autor:innen und Institutionen

  • Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Punjab, India.
  • Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Punjab, India. Electronic address: shamshersingh@isfcp.org.

Förderung

  • JSS College of Pharmacy

Zitieren

APA

Awasthi, V. A., Dhankar, V., & Singh, S. (2024). Novel therapeutic targets for reperfusion injury in ischemic stroke: Understanding the role of mitochondria, excitotoxicity and ferroptosis. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2024.107413

Vancouver

Awasthi VA, Dhankar V, Singh S. Novel therapeutic targets for reperfusion injury in ischemic stroke: Understanding the role of mitochondria, excitotoxicity and ferroptosis. Vascular Pharmacology. 2024. doi:10.1016/j.vph.2024.107413

BibTeX
@article{Awasthi2024,
  author = {Awasthi, Vidhi Anupam and Dhankar, Vaibhav and Singh, Shamsher},
  title = {Novel therapeutic targets for reperfusion injury in ischemic stroke: Understanding the role of mitochondria, excitotoxicity and ferroptosis},
  journal = {Vascular Pharmacology},
  year = {2024},
  doi = {10.1016/j.vph.2024.107413}
}
Kostenlos starten →